Provenance du réseau au premier degré de Christopher J. Barden
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Treventis Corp.
 Treventis Corp. BiotechnologyHealth Technology Treventis Corp. develops a small molecule drugs for Alzheimer's and other protein misfolding diseases. It developed a proprietary discovery platform, a high-resolution three-dimensional model of the common conformational region, enabling rational design of multiple lead compounds. The company was founded by Christopher J. Barden, Donald F. Weaver and Sultan Darvesh in 2008 and is headquartered in Toronto, Canada.
7
| Holding Company | Biotechnology | 7 |
DeNovaMed, Inc.
 DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology DeNovaMed, Inc. develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs. It focuses in the areas of Gram-positive infections, methicillin-resistant Staph and vancomycin-resistant Enterococcus pose a threat to patients in hospitals and community health facilities by producing skin, wound and systemic infections. The firm also has an ongoing discovery program for Gram-negative adjuvants, which can improve the efficacy of older antibacterial. The company was founded by Donald F. Weaver, Christopher R. McMaster and David Byers in 2006 and is headquartered in Halifax, Canada.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Christopher J. Barden via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Dalhousie University | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Robin Hood Ventures
 Robin Hood Ventures Investment ManagersFinance Robin Hood Ventures (RHV) is a venture capital firm founded in 1999 by Rob weber. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Baylor College of Medicine | College/University | Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Canada Research Chairs Program | General Government | Corporate Officer/Principal | |
Neurochem (International) Ltd.
 Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland. | Miscellaneous Commercial Services | Founder | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Doctorate Degree | |
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1985 and is headquartered in Weston, FL. | Pharmaceuticals: Major | Director/Board Member | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Therakos, Inc.
 Therakos, Inc. Medical/Nursing ServicesHealth Services Therakos, Inc. develops immune cell therapies delivered through extracorporeal photopheresis. The firm’s engineers, clinicians and biological researchers have been driven to discover new technologies and therapeutic applications that empower the immune response and improve patient outcomes. It supports clinicians by providing products and training to enhance the treatment of cutaneous T-cell lymphoma (CTCL) and by pursuing additional approved indications for autologous immune cell therapy. The company was founded in 1984 and is headquartered in West Chester, PA. | Medical/Nursing Services | Corporate Officer/Principal | |
The Biotechnology Greenhouse Corp. of Southeastern PA
 The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance The Biotechnology Greenhouse Corp. of Southeastern PA (BioAdvance) is a venture capital firm founded in 2002. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Private Equity Investor | |
| IMMUNOME, INC. | Biotechnology | Director/Board Member | |
| Haffner Associates LLC | Chief Executive Officer | ||
| Uniformed Services University of the Health Sciences | College/University | Corporate Officer/Principal | |
| Johns Hopkins Bloomberg School of Public Health | College/University | Graduate Degree | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
viDA Therapeutics, Inc.
 viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
Annovis, Inc.
 Annovis, Inc. Chemicals: SpecialtyProcess Industries Annovis, Inc. develops, manufactures, and markets a wide variety of nucleic acid based for the life sciences sector. The company is headquartered in Aston, PA. | Chemicals: Specialty | Chief Executive Officer | |
| University of Zagreb | College/University | Doctorate Degree | |
Protez Pharmaceuticals, Inc.
 Protez Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Protez Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It develops antibiotics for infections & provides research service on intravenous & oral small molecule antibiotics to chronic and recurrent infections. The company was founded by Klaus Esser, Luigi Xerri & Christopher M. Cashman in 2003 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member | |
| ANNOVIS BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| The Rockefeller University | College/University | Doctorate Degree | |
Mid-Atlantic Angel Group
 Mid-Atlantic Angel Group Investment ManagersFinance Mid-Atlantic Angel Group operates as a alternative investment manager. The company is headquartered in Philadelphia, PA. | Investment Managers | Director/Board Member | |
| Bachem Bioscience, Inc. | Corporate Officer/Principal | ||
Mallinckrodt LLC
 Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Mallinckrodt LLC is proud to be one of the world's largest suppliers of both controlled substance pain medication and acetaminophen and to have over a century of leadership in helping to diagnose disease through imaging procedures. They are focused on innovative research and development programs, strong clinician relationships and a collaborative approach to new business opportunities. In short, they aim to lead a new generation of patient care by pursuing better, safer, more cost effective ways of diagnosing and treating disease to improve patient outcomes. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| LANTERN PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Translational Development Acquisition Corp.
 Translational Development Acquisition Corp. Financial ConglomeratesFinance Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY. | Financial Conglomerates | Director/Board Member | |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Private Equity Analyst | |
Innovacorp
 Innovacorp Investment ManagersFinance Innovacorp is an independent venture capital firm founded in 1995. The firm is headquartered in Halifax, Nova Scotia, Canada. | Investment Managers | Private Equity Investor | |
| McMaster University | College/University | Masters Business Admin | |
Q-RNA, Inc.
 Q-RNA, Inc. Pharmaceuticals: MajorHealth Technology Q-RNA, Inc. develops drugs for the treatment of Alzheimer's disease. The company was founded on August 30, 2002 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
MedInnova Partners, Inc.
 MedInnova Partners, Inc. Investment ManagersFinance MedInnova Partners, Inc is a venture capital firm, founded in 2000. The firm headquartered in Halifax, Nova Scotia. | Investment Managers | Corporate Officer/Principal | |
| APPILI THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 36 |
| Canada | 12 |
| Royaume-Uni | 2 |
| Suisse | 2 |
| Israël | 2 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 10 |
| Finance | 9 |
| Commercial Services | 3 |
| Government | 3 |
Opérationnelle
| Corporate Officer/Principal | 29 |
| Director/Board Member | 25 |
| Founder | 10 |
| Chief Executive Officer | 5 |
| Independent Dir/Board Member | 5 |
Relations les plus connectées
- Bourse
- Insiders
- Christopher J. Barden
- Connexions Sociétés
